Cargando…

Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery

INTRODUCTION: Smokers undergoing total joint replacement (TJR) are more likely to develop infections and be re-admitted than non-smokers. The primary purpose of this study was to evaluate the effectiveness of standardized preoperative referral to a community-based pharmacist-led smoking cessation pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Beaupre, Lauren A., Hammal, Fadi, DeSutter, Chrisopher, Stiegelmar, Robert E., Masson, Edward, Finegan, Barry A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751968/
https://www.ncbi.nlm.nih.gov/pubmed/31582925
http://dx.doi.org/10.18332/tid/101600
_version_ 1783452714793959424
author Beaupre, Lauren A.
Hammal, Fadi
DeSutter, Chrisopher
Stiegelmar, Robert E.
Masson, Edward
Finegan, Barry A.
author_facet Beaupre, Lauren A.
Hammal, Fadi
DeSutter, Chrisopher
Stiegelmar, Robert E.
Masson, Edward
Finegan, Barry A.
author_sort Beaupre, Lauren A.
collection PubMed
description INTRODUCTION: Smokers undergoing total joint replacement (TJR) are more likely to develop infections and be re-admitted than non-smokers. The primary purpose of this study was to evaluate the effectiveness of standardized preoperative referral to a community-based pharmacist-led smoking cessation program compared to usual care for patients undergoing TJR. Secondarily, we evaluated the use of the smoking cessation program. METHODS: A pre-post quasi-experimental study was conducted at a central intake clinic that prepares approximately 3000 TJR patients annually. Participants were recruited at a mean of 13±11.1 weeks preoperatively and provided informed consent. Participants in the ‘pre’ observational phase (OP) received usual care for smoking cessation. For ‘post’ intervention phase (IP) participants, a referral was sent to a community-based pharmacist-led smoking cessation program. Smoking status was validated on study entry using exhaled carbon monoxide. Participants’ smoking status was re-assessed using self-reported point prevalence abstinence at 6 months post-recruitment. RESULTS: We enrolled 120/150 (80%) potential OP candidates and 104/286 (36%) potential IP candidates. The groups were similar on study entry; overall, the mean age of participants was 58.7±9.1 years and 103 (47%) were male. They reported medium nicotine dependence with 37±11.6 mean years smoked. At 6 months post-recruitment, 8 (7%) OP participants self-reported 30-day point prevalence abstinence compared to 21 (20%) IP participants (p=0.003). Only 58 (56%) IP participants complied with the pharmacist referral, with 19 (33%) of those seeing the pharmacist reporting point prevalence abstinence at 6 months compared to only 2 (4%) of the 45 participants who did not see the pharmacist (p<0.001). CONCLUSIONS: Referral to a community smoking cessation program as preoperative standard of care is feasible and can enhance long-term quit rates, but voluntary participation led to low recruitment to the program.
format Online
Article
Text
id pubmed-6751968
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID)
record_format MEDLINE/PubMed
spelling pubmed-67519682019-10-03 Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery Beaupre, Lauren A. Hammal, Fadi DeSutter, Chrisopher Stiegelmar, Robert E. Masson, Edward Finegan, Barry A. Tob Induc Dis Research Paper INTRODUCTION: Smokers undergoing total joint replacement (TJR) are more likely to develop infections and be re-admitted than non-smokers. The primary purpose of this study was to evaluate the effectiveness of standardized preoperative referral to a community-based pharmacist-led smoking cessation program compared to usual care for patients undergoing TJR. Secondarily, we evaluated the use of the smoking cessation program. METHODS: A pre-post quasi-experimental study was conducted at a central intake clinic that prepares approximately 3000 TJR patients annually. Participants were recruited at a mean of 13±11.1 weeks preoperatively and provided informed consent. Participants in the ‘pre’ observational phase (OP) received usual care for smoking cessation. For ‘post’ intervention phase (IP) participants, a referral was sent to a community-based pharmacist-led smoking cessation program. Smoking status was validated on study entry using exhaled carbon monoxide. Participants’ smoking status was re-assessed using self-reported point prevalence abstinence at 6 months post-recruitment. RESULTS: We enrolled 120/150 (80%) potential OP candidates and 104/286 (36%) potential IP candidates. The groups were similar on study entry; overall, the mean age of participants was 58.7±9.1 years and 103 (47%) were male. They reported medium nicotine dependence with 37±11.6 mean years smoked. At 6 months post-recruitment, 8 (7%) OP participants self-reported 30-day point prevalence abstinence compared to 21 (20%) IP participants (p=0.003). Only 58 (56%) IP participants complied with the pharmacist referral, with 19 (33%) of those seeing the pharmacist reporting point prevalence abstinence at 6 months compared to only 2 (4%) of the 45 participants who did not see the pharmacist (p<0.001). CONCLUSIONS: Referral to a community smoking cessation program as preoperative standard of care is feasible and can enhance long-term quit rates, but voluntary participation led to low recruitment to the program. European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) 2019-02-22 /pmc/articles/PMC6751968/ /pubmed/31582925 http://dx.doi.org/10.18332/tid/101600 Text en © 2019 Beaupre L. A https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License.
spellingShingle Research Paper
Beaupre, Lauren A.
Hammal, Fadi
DeSutter, Chrisopher
Stiegelmar, Robert E.
Masson, Edward
Finegan, Barry A.
Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery
title Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery
title_full Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery
title_fullStr Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery
title_full_unstemmed Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery
title_short Impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery
title_sort impact of a standardized referral to a community pharmacist-led smoking cessation program before elective joint replacement surgery
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751968/
https://www.ncbi.nlm.nih.gov/pubmed/31582925
http://dx.doi.org/10.18332/tid/101600
work_keys_str_mv AT beauprelaurena impactofastandardizedreferraltoacommunitypharmacistledsmokingcessationprogrambeforeelectivejointreplacementsurgery
AT hammalfadi impactofastandardizedreferraltoacommunitypharmacistledsmokingcessationprogrambeforeelectivejointreplacementsurgery
AT desutterchrisopher impactofastandardizedreferraltoacommunitypharmacistledsmokingcessationprogrambeforeelectivejointreplacementsurgery
AT stiegelmarroberte impactofastandardizedreferraltoacommunitypharmacistledsmokingcessationprogrambeforeelectivejointreplacementsurgery
AT massonedward impactofastandardizedreferraltoacommunitypharmacistledsmokingcessationprogrambeforeelectivejointreplacementsurgery
AT fineganbarrya impactofastandardizedreferraltoacommunitypharmacistledsmokingcessationprogrambeforeelectivejointreplacementsurgery